Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder

INTRODUCTION: Patients with major depressive disorder (MDD) incur high costs, despite established treatment options. Adding an atypical antipsychotic (AAP) to antidepressant therapy has shown to reduce depressive symptoms in MDD, but it remains unclear with which adjunctive AAP to initiate. As econo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Tingjian, Greene, Mallik, Chang, Eunice, Houle, Christy R, Tarbox, Marian H, Broder, Michael S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012250/
https://www.ncbi.nlm.nih.gov/pubmed/32104020
http://dx.doi.org/10.2147/CEOR.S231824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012250/
https://www.ncbi.nlm.nih.gov/pubmed/32104020
http://dx.doi.org/10.2147/CEOR.S231824

Ejemplares similares